1. Barefoot J.C., Helms M.J., Mark D.B. et al. Depression and long-term mortality risk in patients with coronary artery disease // Am. J. Cardiol. - 1996. - Vol. 78, № 6. - Р. 613-617.
2. Nemeroff C.B., Musselman D.L. Are platelets the link between depression and ischemic heart disease? // Am. Heart J. - 2000. - Vol. 140, № 4. - P. 57-62.
3. Stahl S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? // Psychopharmacol. Bull. - 1994.- Vol. 30. - P. 39-43.
4. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior // Neuropsychopharmacology. - 1999. - Vol. 21. - P. S99-S105.
5. Pakala R., Willerson J.T., Benedict C.R. Mitogenic effect of serotonin on vascular endotelial cells // Circulation. - 1994. - Vol. 90. - P. 1919-1926.
6. Nilsson T., Longmore J., Shaw D. et al. Characterisation of 5HT receptors in human coronary arteries by molecular and pharmacological techniques // Eur. J. Pharmacol. - 1999. - Vol. 372. - P. 49-56.
7. Plein H., Berk M. The platelet as a peripheral marker in psychiatric illness // Human Psychopharmacol. - 2001. - Vol. 16. - P. 229-236.
8. Willerson J.T. Serotonin and thrombotic complications // J. Cardiovasc. Pharmacol. - 1991. - Vol. 17 (suppl.). - P. 13-20.
9. Maes M., Van der Planken M., Van Gastel A., Desnyder R. Blood coagulation and platelet aggregation in majordepression // J. Affect. Disord. - 1996. - Vol. 40. - P. 35-40.
10. Gomes-Gil E., Gasto C., Diaz-Ricart M. et al. Platelet 5-HT2A - receptor-mediated induction of aggregation is not altered in major depression // Hum. Psychopharmacol. - 2002. - Vol. 17. - P. 419-424.
11. Zigmond A.S., Snaith R.P. The Hospital Anxiety and Depression scale // Acta Psychiatr. Scand. - 1983. - Vol. 67. - P. 361-370.
12. Hamilton M. Hamilton anxiety scale. In: Gue W. ed. ECDEU Assessment manual for psycholopharmacology / Rev. Ed. Washington DC: US Department of Health, Education and Welfare, 1976. - P. 193-198.
13. Hamilton M. A rating for depression // J. Neurol. Neurosurg. Psychiatr. - 1960. - Vol. 23. - P. 56-61.
14. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal // Nature. - 1962. - Vol. 194. - P. 927-929.
15. von Kanel R. Platelet hyperactivity in clinical depression and beneficial effect of antidepressant drug treatment: how strong is the evidence? // Acta Psychiatr. Scand. - 2004. - Vol. 110. - P. 163-177.
16. Nugent D.F., Dinan T.G., Leonard B.E. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed // J. Affect. Disord. - 1995. - Vol. 33. - P. 227-231.
17. Healy D., Calvin J., Whitehouse A.M. et al. Alpha-1-acid glicoprotein in major depression and eating disorders // J. Affect. Disord. - 1991. - Vol. 22. - P. 13-20.
18. Maes M., Smith R., Scharpe S. The monocyt-T-lymphocyte hypothesis of major depression // Psychoneuroendocrinology. - 1995. - Vol. 30. - P. 111-116.
19. Fetkovska N., Fedlesova V., Dzurik R. Low-density lipoprotein amplifies the platelet response to serotonin in human plasma // J. Hypertens. Suppl. - 1989. - Vol. 7, № 6. - P. S164-165.
20. Rosenson R.S., Tanqnev C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction // JAMA. - 1998. - Vol. 279, № 20. - P. 1659-1661.
21. Mehta J., Mehta P. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease // Circulation. - 1982. - Vol. 66. - P. 1294-1299.
22. Sarrias M.J., Artigas F., Martines E. et al. Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures // Biol. Psychiatry. - 1998. - Vol. 26. - P. 695-706.
23. McAdams C., Leonard B.E. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients // Internat. Clin. Psychopharm. - 1992. - Vol. 7. - P. 81-85.
